Hims & Hers Health first-quarter revenue more than doubled as subscribers rose 38%, while its second-quarter sales outlook missed Wall Street’s expectations.

Telehealth company Hims & Hers Health (NYSE:HIMS) reported Q1 CY2025 results , with sales up 111% year on year to $586 million. Revenue guidance for the full year exceeded analysts’ estimates, but next quarter’s guidance of $540 million was less impressive,

Hims & Hers Health ( HIMS) shares surged 8% Tuesday, a day after the health and wellness platform posted better-than-expected results on soaring sales and subscribers. The company reported first-quarter earnings per share of $0.20, with revenue skyrocketing 111% year-over-year to $586.0 million. Both exceeded Visible Alpha estimates.